840487C

18:3 PG

1,2-dilinolenoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

• 別名: 1,2-di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
• 実験式（ヒル表記法）: C₄₂H₇₀O₁₀PNa
• CAS番号: 474943-20-9
• 分子量: 788.96
• UNSPSCコード: 51191904
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• 形状: liquid
• 包装: pkg of 1 × 2.5 mL (840487C-25mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 840487C
• 濃度: 10 mg/mL (840487C-25mg)
• 脂質タイプ: phospholipids
• 輸送温度: dry ice
• 保管温度: −20°C
• InChI: 1S/C42H71O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h5-8,11-14,17-20,39-40,43-44H,3-4,9-10,15-16,21-38H2,1-2H3,(H,47,48);/q;+1/p-1/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-;/t39?,40-;/m1./s1
• InChI Key: JIBYBHPPGFSINU-NYUFXKKKSA-M

詳細

詳細

18:3 PG or 1,2-dilinolenoyl-sn-glycero-3-phospho-(1′-rac-glycerol) is a sodium salt of glycerophospholipid with substitution of two linolenic acids at sn-1 and sn-2 positions and phospho-(1′-rac-glycerol) at the sn-3 position of the glycerol backbone.

包装

5 mL Clear Glass Sealed Ampule (840487C-25mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 注意書き: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• ターゲットの組織: Central nervous system, Liver,Kidney
• WGK: WGK 3